Related Experiment Video
Updated: Jul 19, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Hydranencephaly with cholestasis and giant hepatitis
Hisashi Kawashima1, Chiako Watanabe, Shigeo Nishimata
1Department of Pediatrics, Tokyo Medical University, Tokyo, Japan. hisashi@tokyo-med.ac.jp
This case report describes a rare condition where a patient had hydranencephaly, a severe brain malformation, along with cholestasis and giant hepatitis. Despite normal pituitary function, the patient showed severe liver disease. No infectious agents were found, suggesting a non-infectious cause for the liver abnormalities. The authors propose that this combination of conditions is uncommon and may represent a new clinical entity. This case highlights the importance of thorough diagnostic evaluation in complex pediatric cases.
Area of Science:
- Pediatric neurology and hepatology
- Genetic and metabolic disorders
- Neurodevelopmental anomalies
Background:
Hydranencephaly is a rare congenital brain malformation where most of the cerebral hemispheres are absent or filled with fluid. While hydranencephaly is often associated with other systemic anomalies, the combination with cholestasis and giant hepatitis is exceptionally uncommon. Prior research has documented hydranencephaly in the context of various genetic syndromes and prenatal insults, but no prior work had resolved the specific mechanisms linking hydranencephaly with cholestatic liver disease. This gap motivated further investigation into the co-occurrence of these conditions. It was already known that cholestasis can arise from genetic, metabolic, or infectious origins. However, the absence of identifiable infectious agents in this case raised new questions about the underlying etiology. Researchers have previously explored the role of the anterior pituitary in metabolic regulation, but this case presented normal pituitary function despite severe liver pathology. The lack of a clear cause for the liver abnormalities in this patient highlighted the need for more detailed case studies.
Purpose Of The Study:
The aim of this case report is to describe a rare presentation of hydranencephaly combined with cholestasis and giant hepatitis. The specific problem addressed is the lack of understanding regarding the etiology of cholestatic liver disease in the absence of known infectious or metabolic causes. This patient's condition challenges existing diagnostic paradigms. The motivation for this study stems from the need to document and analyze such rare cases to expand clinical knowledge. By presenting this case, the authors hope to contribute to the differential diagnosis of neonatal cholestasis. The study also seeks to highlight the importance of comprehensive diagnostic evaluation in complex pediatric cases. The authors propose that this case may represent a novel or under-recognized clinical entity. This case adds to the literature on hydranencephaly and its associated systemic manifestations.
Main Methods:
The study employed a clinical case report approach to document the patient's presentation and diagnostic process. The patient's medical history was reviewed, including neurological and hepatic findings. Laboratory investigations included testing for infectious agents using polymerase chain reaction on liver tissue. The anterior pituitary function was assessed through measurements of cortisol, thyroid stimulating hormone, free T4, and human growth hormone. The absence of identifiable pathogens was confirmed through comprehensive testing. The authors analyzed the patient's clinical course and response to treatment. The study focused on correlating neurological findings with hepatic abnormalities. The authors used a descriptive approach to highlight the unique aspects of this case.
Main Results:
The patient exhibited hydranencephaly confirmed through imaging studies. Despite normal anterior pituitary function, the patient presented with massive cholestasis and giant hepatitis. Testing for infectious agents, including viral detection in liver tissue, was negative. The absence of identifiable pathogens suggests a non-infectious cause for the liver disease. The patient's neurological findings were consistent with hydranencephaly. Liver function tests revealed severe cholestatic abnormalities. The authors observed no improvement in liver function despite standard treatment approaches. The case highlights the complexity of diagnosing cholestatic liver disease in the context of hydranencephaly.
Conclusions:
The authors propose that this case represents a rare and under-recognized clinical entity. The combination of hydranencephaly with cholestasis and giant hepatitis is extremely uncommon. The absence of identifiable infectious agents suggests a non-infectious etiology for the liver disease. The authors emphasize the importance of comprehensive diagnostic evaluation in such cases. This case adds to the literature on hydranencephaly and its associated systemic manifestations. The authors suggest that further investigation is needed to understand the underlying mechanisms. The study highlights the need for multidisciplinary approaches in managing complex pediatric cases. The authors conclude that this case may expand the differential diagnosis for neonatal cholestasis.
Frequently Asked Questions
The authors propose that this combination is extremely rare and may represent a novel clinical entity. This case highlights the need for further investigation into the underlying mechanisms.
The patient's liver tissue was tested using polymerase chain reaction, and all infectious agents were found to be negative.
Despite normal pituitary function, the patient exhibited severe liver pathology, suggesting a non-endocrine cause for the cholestasis.
The patient underwent imaging studies, laboratory tests for infectious agents, and assessment of anterior pituitary function.
This case expands the differential diagnosis for neonatal cholestasis and highlights the importance of comprehensive evaluation in complex pediatric cases.
The authors suggest that non-infectious causes may be responsible for cholestatic liver disease in this patient.
Related Concept Videos
Hepatic Encephalopathy
Cirrhosis I: Introduction
Portal Hypertension
Cirrhosis II: Pathophysiology
Hepatitis
Jaundice
